The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Spice drugs as a new trend: Mode of action, identification and legislation
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Pharmacological Basis of Therapeutics
(1976) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/33.4.373a · Cited by 8,209
International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
Howlett, A. C., Barth, F., Bonner, T. I., Cabral, G., Casellas, P., Devane, W. A., Felder, C. C., Herkenham, M., Mackie, K., Martin, B. R., et al. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.161 · Cited by 2,819
Cannabinoid pharmacology: the first 66 years
Pertwee, R. G. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706406 · Cited by 782
‘Spice’ and other herbal blends: harmless incense or cannabinoid designer drugs?
Auwärter, V., Dresen, S., Weinmann, W., Müller, M., Pütz, M., & Ferreirós, N. (2009) · Journal of Mass Spectrometry · doi:10.1002/jms.1558 · Cited by 660
Jiang, W. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25509 · Cited by 527
Compton, D. R., Rice, K. C., De Costa, B. R., Razdan, R. K., Melvin, L. S., Johnson, M. R., & Martin, B. R. (1993) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38122-x · Cited by 461
Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis
Morgan, C. J. A., & Curran, H. V. (2008) · British Journal of Psychiatry · doi:10.1192/bjp.bp.107.046649 · Cited by 300
Lindigkeit, R., Boehme, A., Eiserloh, I., Luebbecke, M., Wiggermann, M., Ernst, L., & Beuerle, T. (2009) · Forensic Science International · doi:10.1016/j.forsciint.2009.06.008 · Cited by 299
Agonist Selective Regulation of G Proteins by Cannabinoid CB1 and CB2 Receptors
Glass, M., & Northup, J. K. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12404-2 · Cited by 298
Withdrawal Phenomena and Dependence Syndrome After the Consumption of „Spice Gold“
Zimmermann, U. S., Winkelmann, P. R., Pilhatsch, M., Nees, J. A., Spanagel, R., & Schulz, K. (2009) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2009.0464 · Cited by 278
Design, Synthesis and Pharmacology of Cannabimimetic Indoles
Huffman, J. W., Dai, D., Martin, B. R., & Compton, D. R. (1994) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)80155-4 · Cited by 275
Influence of the N-1 alkyl chain length of cannabimimetic indoles upon CB1 and CB2 receptor binding
Aung, M. M., Griffin, G., Huffman, J. W., Wu, M.-J., Keel, C., Yang, B., Showalter, V. M., Abood, M. E., & Martin, B. R. (2000) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(99)00152-0 · Cited by 254
Chemical analysis of synthetic cannabinoids as designer drugs in herbal products
Uchiyama, N., Kikura-Hanajiri, R., Ogata, J., & Goda, Y. (2010) · Forensic Science International · doi:10.1016/j.forsciint.2010.01.004 · Cited by 245
Grotenhermen, F. (2004) · PubMed · Cited by 232
Detection of JWH-018 metabolites in smoking mixture post-administration urine
Sobolevsky, T. G., Prasolov, I., & Rodchenkov, G. M. (2010) · Forensic Science International · doi:10.1016/j.forsciint.2010.04.003 · Cited by 219
Teske, J., Weller, J.-P., Fieguth, A., et al. (2010) · Journal of Chromatography B · doi:10.1016/j.jchromb.2010.03.016 · Cited by 216
Compton, D. R., Johnson, M. R., Melvin, L. S., & Martin, B. R. (1992) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)11216-0 · Cited by 215
Enantiomeric cannabinoids: stereospecificity of psychotropic activity
Mechoulam, R., Feigenbaum, J. J., Lander, N., Segal, M., Järbe, T. U. C., Hiltunen, A. J., & Consroe, P. (1988) · Experientia · doi:10.1007/bf01959156 · Cited by 208
Pertwee, R. G. (2005) · The AAPS Journal · doi:10.1208/aapsj070364 · Cited by 203
Müller, H., Sperling, W., Köhrmann, M., Huttner, H. B., Kornhuber, J., & Maler, J.-M. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2009.12.001 · Cited by 183
Fergusson, D. M., Poulton, R., Smith, P. F., & Boden, J. M. (2006) · BMJ · doi:10.1136/bmj.332.7534.172 · Cited by 178
Identification of a cannabimimetic indole as a designer drug in a herbal product
Uchiyama, N., Kikura‐Hanajiri, R., Kawahara, N., & Goda, Y. (2009) · Forensic Toxicology · doi:10.1007/s11419-009-0069-y · Cited by 141
Cannabinoids: A New Group of Agonists of PPARs
Sun, Y., & Bennett, A. (2007) · PPAR Research · doi:10.1155/2007/23513 · Cited by 115
Chin, C., Murphy, J. W., Huffman, J. W., et al. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35174-2 · Cited by 75
Robinson, L., Goonawardena, A. V., Pertwee, R. G., Hampson, R. E., & Riedel, G. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707273 · Cited by 66
HU 210: A Potent Tool for Investigations of the Cannabinoid System
Ottani, A., & Giuliani, D. (2001) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2001.tb00192.x · Cited by 61
Investigating a not-so-natural high
Piggee, C. A. (2009) · Analytical Chemistry · doi:10.1021/ac900564u · Cited by 59
Dalton, V. S., Wang, H., & Zavitsanou, K. (2009) · Neurochemical Research · doi:10.1007/s11064-009-9914-y · Cited by 38
Nabemoto, M., Mashimo, M., Someya, A., Nakamura, H., Hirabayashi, T., Fujino, H., Kaneko, M., Okuma, Y., Saito, T., Yamaguchi, N., et al. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.04.064 · Cited by 13
Cited by
Sommermeyer, D., Hudecek, M., Kosasih, P. L., Gogishvili, T., Maloney, D. G., Turtle, C. J., & Riddell, S. R. (2016) · Leukemia · doi:10.1038/leu.2015.247 · Cited by 867
Seely, K. A., Lapoint, J., Moran, J. H., & Fattore, L. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.04.017 · Cited by 465
Beyond THC: The New Generation of Cannabinoid Designer Drugs
Fattore, L., & Fratta, W. (2011) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2011.00060 · Cited by 443
Tait, R. J., Caldicott, D., Mountain, D., Hill, S. L., & Lenton, S. (2016) · Clinical Toxicology · doi:10.3109/15563650.2015.1110590 · Cited by 378
Rosenbaum, C. D., Carreiro, S. P., & Babu, K. M. (2012) · Journal of Medical Toxicology · doi:10.1007/s13181-011-0202-2 · Cited by 355
Metadata
- Authors
- Vardakou, I., Pistos, C., & Spiliopoulou, C.
- Venue
- Toxicology Letters
- Publisher
- Elsevier BV
- Published
- 2010-09-01
- Volume
- 197
- Issue
- 3
- Pages
- 157-162
- ISSN
- 0378-4274 (ISSN-L)
- OpenAlex
- W2118678357
- Cited by
- 341
- References
- 29
- FWCI
- 53.77
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.